• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NOX

NOXOPHARM LIMITED

4.35% ! 11.0¢
Market Cap $32.14M  !

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel... Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NOX 07:30 7 1.6K
07:30 Last post  19661966 Comments Created with Sketch.  7  Views Created with Sketch.  1.6K 
NOX 04/08/25 4 1.3K
04/08/25 Last post  Bendunstan Comments Created with Sketch.  4  Views Created with Sketch.  1.3K 
NOX 29/07/25 5 2.2K
29/07/25 Last post  Pierzzxx Comments Created with Sketch.  5  Views Created with Sketch.  2.2K 
NOX 21/07/25 3 1.9K
21/07/25 Last post  19661966 Comments Created with Sketch.  3  Views Created with Sketch.  1.9K 
NOX
Noxopharm gets HERACLES autoimmune trials started with first human doses
16/07/25 0 310
16/07/25 Last post  ASX Insights Comments Created with Sketch.  0  Views Created with Sketch.  310 
NOX 11/07/25 9 3.5K
11/07/25 Last post  Bendunstan Comments Created with Sketch.  9  Views Created with Sketch.  3.5K 
NOX 24/06/25 19 6.1K
24/06/25 Last post  19661966 Comments Created with Sketch.  19  Views Created with Sketch.  6.1K 
NOX 10/06/25 4 1.8K
10/06/25 Last post  19661966 Comments Created with Sketch.  4  Views Created with Sketch.  1.8K 

See All Discussions arrow Created with Sketch.

Timeline

US company demonstrates strong Sofra potential
05 Aug 08:28
 
June 2025 Quarterly Activities Report and Appendix 4C
30 Jul 08:30
 
HERACLES clinical trial - Update 1
28 Jul 09:39
 
First SOF-SKN dose in HERACLES clinical trial
16 Jul 08:14
 
Clinical trial recruitment progressing rapidly
25 Jun 10:08
 
Promising Sofra results from overseas company
11 Jun 11:11
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
11.0¢
Change
-0.005(4.35%)
Mkt cap ! $32.14M
Open High Low Value Volume
11.5¢ 11.5¢ 10.5¢ $25.63K 234.3K

Buyers (Bids)

No. Vol. Price($)
2 85785 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 109573 3
View Market Depth
Last trade - 15.55pm 07/08/2025 (20 minute delay) ?
Last
11.5¢
  Change
-0.005 ( 4.55 %)
Open High Low Volume
11.5¢ 11.5¢ 10.5¢ 192398
Last updated 14.48pm 07/08/2025 ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.